Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: A comparison of three basal insulins

Diabetic Medicine

Volumn 26, Issue 10, 2009, Pages 1027-1032

  Arutchelvam, V ^a   Heise, T ^b   Dellweg, S ^b   Elbroend, B ^c   Minns, I ^a   Home, P D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Profil Institut fur Stoffwechselforschung   (Germany)

^c Novo Nordisk Ltd   (United Kingdom)

Author keywords

Exercise; Insulin detemir; Insulin glargine; NPH insulin; Type 1 diabetes

Indexed keywords

ADRENALIN; GLUCOSE; HYDROCORTISONE; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; NORADRENALIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ERUPTION; EPIDIDYMITIS; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, NPH; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349499375     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02807.x     Document Type: Article

References (14)

1. Sato Y. Diabetes and lifestyles: role of physical exercise for primary prevention. Br J Nutr 2000 84 : S187 S190.
2. Berger M, Hagg S, Ruderman NB. Glucose metabolism in perfused skeletal muscle. Interaction of insulin and exercise on glucose uptake. Biochem J 1975 146 : 231 238.
3. Marliss EB, Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes. Diabetes 2002 51 : S271 S283.
4. Riddell MC, Perkins BA. Type 1 diabetes and vigorous exercise: applications of exercise physiology to patient management. Can J Diabetes 2006 30 : 63 71.
5. MacDonald MJ. Post-exercise late-onset hypoglycemia in insulin-dependent diabetic patients. Diabetes Care 1987 10 : 584 588.
6. Thow JC, Johnson AB, Antsiferov M, Home PD. Exercise augments the absorption of isophane (NPH) insulin. Diabet Med 1989 6 : 342 345.
7. Kurtzhals P. Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir. Int J Obes Relat Metab Disord 2004 28 : S23 S28.
8. Home P, Kurtzhals P. Insulin detemir: from concept to clinical experience. Expert Opin Pharmacother 2006 7 : 325 343.
9. Herz M, Profozic V, Arora V. Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes. Curr Med Res Opin 2002 18 : 188 193.
10. Heise T, Nosek L, Ronn B, Endahl L, Heinemann L, Kapitza C et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004 53 : 1614 1620.
11. Lepore M, Pampanelli S, Fanelli C. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000 49 : 2142 2148.
12. Heise T, Pieber TR. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab 2007 9 : 648 659.
13. Ashwell S, Gebbie J, Home P. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart. Diabet Med 2006 23 : 879 886.
14. Peter R, Stephen DL, Dunseath G, Miles A, Hare B, Backx K et al. Effects of exercise on the absorption of insulin glargine on persons with type 1 diabetes mellitus. Diabetes Care 2005 28 : 560 565.